AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Alvaro Carvallo
Allergist and Clinical Immunologist
Spain
Public Documents
1
October 14, 2022
Fenebrutinib and BTK inhibition: unveiling a new target for the treatment of chronic...
Sergio Sánchez Fernández, Carvallo A, Morales-Palacios MP, et al.